ArticlePathology oncology research : POR2009
Histochemical contributions to the binding mechanism of complement (CR1, CR2) receptors.
Article in Pathology oncology research : POR, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complement receptors (CR1, CR2, CR3), and their ligands (C3b, C3d, iC3b) are essentially involved in germinal center development and in binding, trapping, and retaining immunocomplexes. Methods studying complement receptor (CR1/CR2)-ligand (C3b/C3d) interactions mostly involve coating of sheep erythrocytes (E), sheep erythrocyte-antisheep erythrocyte antibody (EA complexes) and whole human (h) or mouse (m) sera as a source of complement, EACh/m complexes, as reagents. The observation of Dukor et al. (1970), that EACm complexes in native cryostat sections bind selectively and very strongly to the B lymphocyte regions of lymphoid organs allowed the topo-histochemical analysis of receptor (CR1/CR2)-ligand (C3b/C3d) interactions in such an immunologically important area as the germinal centers. The main finding of this study is, that periodic acid pretreatment of unfixed cryostat tonsil sections-oxidizing vicinal glycol groups of polysaccharide chains into dialdehydes-completely abolished the binding of all EAC/EC complexes to germinal center area. It may suggest the involvement of receptor carbohydrate in C3 receptor/ligand binding. In addition to, the subsequent sodium borohydride reduction-converting aldehydes (produced by periodic acid oxidation) into primary alcohols-restored selectively the binding of all applied EAC/EC complexes to follicular centers. These in vitro topo-histochemical studies give a strong hint for the participation of-OH groups of sugar residues in CR1/CR2 ligand (C3b/C3d) binding.
Indexed as
Identifiers
19353305What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.